A novel Diclofenac-carrier for local treatment of osteoarthritis applying live-animal MRI

Journal of Controlled Release

Volumn 135, Issue 1, 2009, Pages 65-70

  Elron Gross, Inbar ^a   Glucksam, Yifat ^a   Biton, Inbal E ^a   Margalit, Rimona ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Drug carrier; Local administration; MRI; NSAIDs; Osteoarthritis

Indexed keywords

DRUG-CARRIER; LOCAL ADMINISTRATION; MRI; NSAIDS; OSTEOARTHRITIS;

COLLAGEN; ENCAPSULATION; INTERNET; LEAKAGE (FLUID);

ANIMALS;

COLLAGEN; DICLOFENAC; DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; DRUG CARRIER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SAFETY; DRUG STRUCTURE; ENCAPSULATION; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PRIORITY JOURNAL; RAT; SIMULATION; SINGLE DRUG DOSE; SYNOVIAL FLUID;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLLAGEN TYPE I; DELAYED-ACTION PREPARATIONS; DICLOFENAC; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG COMPOUNDING; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICROSCOPY, ELECTRON, SCANNING; OSTEOARTHRITIS; PHOSPHATIDYLETHANOLAMINES; RATS; RATS, WISTAR; SURFACE PROPERTIES;

EID: 61649099254     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2008.12.005     Document Type: Article

References (33)

1. Braunwald E. Harrison's Principles of Internal Medicine (2001), McGraw-Hill, New York
2. Ge Z., Hu Y., Heng B.C., Yang Z., Ouyang H., Lee E.H., and Cao T. Osteoarthritis and therapy. Arthritis Rheum. 55 3 (2006) 493-500
3. Saravanan M., Bhaskar K., Maharajan G., and Pillai K.S. Ultrasonically controlled release and targeted delivery of diclofenac sodium via gelatin magnetic microspheres. Int. J. Pharm. 283 1-2 (2004) 71-82
4. Towheed T.E. Pennsaid therapy for osteoarthritis of the knee: a systematic review and metaanalysis of randomized controlled trials. J. Rheumatol. 33 3 (2006) 567-573
5. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69 (2000) 145-182
6. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 97-120
7. Gerwin N., Hops C., and Lucke A. Intraarticular drug delivery in osteoarthritis. Adv. Drug. Deliv. Rev. 58 2 (2006) 226-242
8. Cevc G., and Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim. Biophys. Acta 1514 2 (2001) 191-205
9. Khazaeinia T., and Jamali F. A comparison of gastrointestinal permeability induced by diclofenac-phospholipid complex with diclofenac acid and its sodium salt. J. Pharm. Pharm. Sci. 6 3 (2003) 352-359
10. Khazaeinia T., and Jamali F. Effect of drug release rate on therapeutic outcomes: formulation dependence of gastrointestinal toxicity of diclofenac in the rat. Inflammopharmacology 12 1 (2004) 69-80
11. Tsai M.F., Chiang Y.L., Wang L.F., Huang G.W., and Wu P.C. Oral sustained delivery of diclofenac sodium using calcium chondroitin sulfate matrix. J. Biomater. Sci., Polym. Ed. 16 10 (2005) 1319-1331
12. Goodman L.S., Hardman J.G., Limbird L.E., and Gilman A.G. Goodman & Gilman's the Pharmacological Basis of Therapeutics (2001), McGraw-Hill, New York
13. Chamouard J.M., Barre J., Urien S., Houin G., and Tillement J.P. Diclofenac binding to albumin and lipoproteins in human serum. Biochem. Pharmacol. 34 10 (1985) 1695-1700
14. Larsen C., Ostergaard J., Larsen S.W., Jensen H., Jacobsen S., Lindegaard C., and Andersen P.H. Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. J. Pharm. Sci. 97 11 (2008) 4622-4654
15. Cevc G., Mazgareanu S., and Rother M. Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels. Int. J. Pharm. 360 1-2 (2008) 29-39
16. Thakkar H., Sharma R.K., Mishra A.K., Chuttani K., and Murthy R.R. Albumin microspheres as carriers for the antiarthritic drug celecoxib. AAPS PharmSciTech 6 1 (2005) E65-73
17. D.A.M. Peer, R, Patent application PCT/US2005/0243532005.
18. Yerushalmi N., and Margalit R. Bioadhesive, collagen-modified liposomes: molecular and cellular level studies on the kinetics of drug release and on binding to cell monolayers. Biochim. Biophys. Acta. 1189 1 (1994) 13-20
19. Yerushalmi N., and Margalit R. Hyaluronic acid-modified bioadhesive liposomes as local drug depots: effects of cellular and fluid dynamics on liposome retention at target sites. Arch. Biochem. Biophys. 349 1 (1998) 21-26
20. Margalit R. liposomal drug delivery: thermodynamic and chemical kinetic consideration. J. Control. Release 17 3 (1991) 285-296
21. Cestelli A., Catania C., D'Agostino S., Di Liegro I., Licata L., Schiera G., Pitarresi G.L., Savettieri G., De Caro V., Giandalia G., and Giannola L.I. Functional feature of a novel model of blood brain barrier: studies on permeation of test compounds. J. Control. Release 76 1-2 (2001) 139-147
22. Fischer S., Arad A., and Margalit R. Liposome-formulated enzymes for organophosphate scavenging: butyrylcholinesterase and Demeton-S. Arch. Biochem. Biophys. 434 1 (2005) 108-115
23. Levin G., Kariv N., Khomiak E., and Raz A. Indomethacin inhibits the accumulation of tumor cells in mouse lungs and subsequent growth of lung metastases. Chemotherapy 46 6 (2000) 429-437
24. Elron-Gross I., Glucksam Y., Melikhov D., and Margalit R. Cyclooxygenase inhibition by diclofenac formulated in bioadhesive carriers. Biochim. Biophys. Acta 1778 4 (2008) 931-936
25. Guzman R.E., Evans M.G., Bove S., Morenko B., and Kilgore K. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol. Pathol. 31 6 (2003) 619-624
26. Guingamp C., Gegout-Pottie P., Philippe L., Terlain B., Netter P., and Gillet P. Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum. 40 9 (1997) 1670-1679
27. Pomonis J.D., Boulet J.M., Gottshall S.L., Phillips S., Sellers R., Bunton T., and Walker K. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 114 3 (2005) 339-346
28. Bove S.E., Calcaterra S.L., Brooker R.M., Huber C.M., Guzman R.E., Juneau P.L., Schrier D.J., and Kilgore K.S. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthr. Cartil. 11 11 (2003) 821-830
29. Loeuille D., Gonord P., Guingamp C., Gillet P., Blum A., Sauzade M., and Netter P. In vitro magnetic resonance microimaging of experimental osteoarthritis in the rat knee joint. J. Rheumatol. 24 1 (1997) 133-139
30. Jiang Y., Zhao J., White D.L., and Genant H.K. Micro CT and Micro MR imaging of 3D architecture of animal skeleton. J. Musculoskelet. Neuronal. Interact. 1 1 (2000) 45-51
31. Clinical trial phase III Efficacy and safety of Diclofenac Sodium Gel (DSG) in knee Osetoarthritis (NCT00426621) ClinicalTrials.gov Identifier 2007.
32. Tuncay M., Calis S., Kas H.S., Ercan M.T., Peksoy I., and Hincal A.A. In vitro and in vivo evaluation of diclofenac sodium loaded albumin microspheres. J. Microencapsul 17 2 (2000) 145-155
33. Rother M., Lavins B.J., Kneer W., Lehnhardt K., Seidel E.J., and Mazgareanu S. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. Ann. Rheum. Dis. 66 9 (2007) 1178-1183